This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

The UK’s drugs regulator has advised healthcare professionals to alert RSV vaccine recipients to Guillain-Barré syndrome symptoms, although the risk remains low.

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

The MHRA highlights that some reactions may simply be coincidence. For example, a patient given an RSV jab may develop Guillain-Barre syndrome, but the vaccine itself may not be responsible.

During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...

Guillain-Barré Syndrome & Other Serious Neurological Adverse Events Following Vaccination Until now, medical science cannot completely explain the cause of or mechanisms behind the development of ...

Of all the autoimmune diseases out there, Guillain-Barre syndrome is definitely one of the less common. This condition, which affects the body's nerves and causes muscle weakness that develops into ...

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

The findings suggest a novel explanation for how vaccines produce this effect. Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

August Roofing & Solar has been a trusted name for homeowners across Southern California seeking high-quality roofing and ...

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the recombinant shingles vaccine (Shingrix) -- were tied to a lower dementia risk ...